“Fractional Carbon Dioxide Laser Versus UVA 1 in Treatment of Localized Scleroderma,” a clinical trial…
Maureen Newman
Maureen Newman is a researcher by trade, and brings her knowledge of the lab to BioNews Texas. Currently, she is serving as a PhD student at University of Rochester, and working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit’s laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment. She is a senior science and research columnist for BioNews Texas.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Maureen Newman
An ongoing clinical trial is evaluating RoActemra/Actemra (tocilizumab) in patients with systemic sclerosis (SSc). Sponsored…
Certain patients with systemic sclerosis (SSc) may be at a higher risk for malignancies based on autoantibodies present in…
Fibrosis and metabolism: the two were recently linked in a study presented at the 2014 American College of Rheumatology…
New Scleroderma-related findings have linked two variations of the disease, which in turn could lead to effective, new…
A group from Massachusetts General Hospital is placing possible blame for systemic sclerosis (SSc) pathogenesis on autotaxin (ATX), an enzyme…
Federal University of SĂ£o Paulo recently initiated a phase 3 clinical trial evaluating the use of probiotics in patients…
At times, a major roadblock to conducting clinical trials is enrolling enough patients to fill a study for appropriate…
Recently, autologous haematopoietic stem cell transplantation (AHSCT) has become more popular in treating patients with systemic sclerosis (SSc).
Closely examining the capillaries of the fingers, perhaps one of the most non-invasive procedures possible, may be provide insight…